Skip to main content
Ipsen logo

Ipsen — Investor Relations & Filings

Ticker · IPN ISIN · FR0010259150 LEI · 549300M6SGDPB4Z94P11 PA Manufacturing
Filings indexed 1,378 across all filing types
Latest filing 2025-12-04 M&A Activity
Country FR France
Listing PA IPN

Ipsen is a global biopharmaceutical company focused on innovation and specialty care. The company develops and commercializes transformative medicines to address high unmet medical needs in three key therapeutic areas: oncology, rare diseases, and neuroscience. By leveraging its specialized expertise and strategic partnerships, Ipsen aims to accelerate the development of new therapies and improve health outcomes for patients worldwide. Its strategy is centered on advancing science with purpose to bring innovative treatments from research and development to the market.

Recent filings

Filing Released Lang Actions
Communication relative à l'actionnariat d'Ipsen
M&A Activity Classification · 1% confidence The document announces a change in the ownership structure of a major shareholder (Beech Tree) of Ipsen, following the death of Henri Beaufour. It details the transfer of shares to a foundation and mentions regulatory approvals. This type of disclosure regarding significant shareholding changes and ownership structure does not fit into specific categories like 'Director's Dealing' (which is for individual trades) or 'Major Shareholding Notification' (which is typically a formal regulatory filing for threshold crossings). Given the nature of the announcement regarding corporate control and shareholding, it is best classified as a general regulatory announcement.
2025-12-04 French
Ipsen annonce avec une profonde tristesse le décès de Henri Beaufour, membre de son conseil d'administration issu de la famille fondatrice
Board/Management Information Classification · 1% confidence The document is a press release announcing the death of a member of the Board of Directors (Henri Beaufour). While it mentions the Board of Directors, it is specifically an announcement regarding a change in the composition of the board due to a death, which falls under the category of Board/Management Information. It does not fit into the other categories like 10-K, ER, or RNS as it is a specific corporate announcement regarding personnel.
2025-12-01 French
Ipsen mourns the passing of Henri Beaufour, a founding family Board member
Board/Management Information Classification · 1% confidence The document is a press release announcing the passing of a Board member, Henri Beaufour. It discusses the impact on the Board and the company's leadership. While it mentions the Board of Directors, it is not a formal notification of a change in board composition (like an appointment or resignation) but rather an obituary/announcement of a death. Since it does not fit into specific categories like MANG (which typically covers appointments/resignations) or other financial reporting categories, it falls under the general regulatory announcement category (RNS) used for corporate news and miscellaneous filings.
2025-12-01 English
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 47 - 2025
Transaction in Own Shares Classification · 1% confidence The document is a detailed report of share buyback transactions (transactions in own shares) conducted by the company IPSEN between November 17 and November 21, 2025. It includes tables detailing daily volumes, average prices, and individual transaction references, which is characteristic of a 'Transaction in Own Shares' (POS) filing.
2025-11-25 English
IPSEN - Buy-back programme - Art 5 of MAR - Week 47 - 2025
Transaction in Own Shares Classification · 1% confidence The document is a detailed report of 'transactions in own shares' for the company IPSEN, covering a specific period (17th to 21st November 2025). It includes tables detailing daily volumes, weighted average prices, and individual transaction records (broker, time, price, quantity, and purpose). This aligns perfectly with the definition of 'Transaction in Own Shares' (POS), which covers share buyback reporting.
2025-11-25 English
IPSEN - Buy-back programme - Art 5 of MAR - Week 46 - 2025
Transaction in Own Shares Classification · 1% confidence The document is a detailed report of 'transactions in own shares' (share buybacks) for the company IPSEN, covering a specific period (10th November to 14th November 2025). It includes tables detailing daily volumes, weighted average prices, and individual transaction records with broker information and purpose ('RACHAT ACTIONS IPSEN'). This aligns perfectly with the definition for 'Transaction in Own Shares' (POS).
2025-11-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.